Results from the long-awaited US trial of the Oxford-AstraZeneca Covid vaccine are out and confirm that the shot is both safe and highly effective.

The COVID-19 vaccine developed by AstraZeneca and Oxford University was found to be 79% effective in preventing symptomatic illness in a large trial in Chile, Peru, and the United States.

And was 100% effective against severe or critical disease and hospitalisation.

The study included over 32,000 volunteers across all age groups, and the results could help it get emergency authorization from the US Food and Drug Administration.

The data - which the company released on Monday should boost faith in the British shot after results from earlier, separate studies raised questions about the robustness of the data.

And allay safety concerns after some European countries briefly halted the use of the AstraZeneca vaccine earlier this month following reports it was linked to blood clots.

Many have since resumed vaccinations after a regional regulator said it was safe, but a survey on Monday showed Europeans remained sceptical.

Leaders in Asia have sought to boost public confidence by taking the AstraZeneca shot themselves.

The AstraZeneca shot was among the first and cheapest of the COVID-19 vaccines to be developed and launched on a large scale.

It is set to be the key vaccination programme in much of the developing world.

Read more
How EU sabotaged fight against Covid as ‘HALF of Germany, France and Spain now believe AstraZeneca jab is unsafe’
[ Ссылка ]

From Brexit breaking news to HD movie trailers, The Sun newspaper brings you the latest news videos and explainers from the UK and around the world.

Become a Sun Subscriber and hit the bell to be the first to know

Read The Sun: [ Ссылка ]
Like The Sun on Facebook: [ Ссылка ]
Follow The Sun on Twitter: [ Ссылка ]
Subscribe to The Sun on Snapchat: [ Ссылка ]

свернуть